NHS: Drugs

Department of Health and Social Care written question – answered on 22nd March 2018.

Alert me about debates like this

Photo of Lord Sharkey Lord Sharkey Liberal Democrat

To ask Her Majesty's Government what plans they have to facilitate the adoption of off-patent, repurposed drugs into NHS clinical practice where these would benefit patients.

Photo of Lord Sharkey Lord Sharkey Liberal Democrat

To ask Her Majesty's Government whether they intend to review how they can incentivise manufacturers of generic medicines to ensure off-patent medicines can be repurposed and made available to patients.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

The Association of Medical Research Charities (AMRC) has led a group of stakeholders which has produced a framework to facilitate the adoption of off-patent repurposed drugs into National Health Service clinical practice where there is robust evidence to support it and where this would benefit patients. This, alongside some recommendations which will further support drug repurposing, was published in their report last year, Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice. A copy is attached.

The Department has supported this work and is playing its part in implementing the recommendations which fall within its area of responsibility. We have no plans to further review how generic manufacturers can be incentivised. The AMRC’s report includes two recommendations which relate to incentives for generic manufacturers which are for a range of other stakeholders to drive forward. However, we took an important step forward in incentivising medicines manufacturers to repurpose drugs in ensuring that the Accelerated Access Pathway announced last November is open to repurposed drugs.

Drug Repurposing Report (PDF Document, 1.35 MB)

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.